Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-115,100
Closed -$460K 5942
2015
Q3
$460K Buy
+115,100
New +$625K ﹤0.01% 3412
2015
Q1
Sell
-3,500
Closed -$21K 7043
2014
Q4
$21K Hold
3,500
﹤0.01% 6287
2014
Q3
$21K Hold
3,500
﹤0.01% 6443
2014
Q2
$25K Sell
3,500
-2,000
-36% -$14.7K ﹤0.01% 6387
2014
Q1
$39K Sell
5,500
-82,000
-94% -$574K ﹤0.01% 6183
2013
Q4
$613K Buy
+87,500
New +$640K ﹤0.01% 3893

Other funds holding ABEV

Barclays's ABEV Position: Q1 2026 in Review

Barclays opened a new position in Ambev (ABEV) in Q1 2026: 682 shares worth $1.99K. The stake represents ﹤0.01% of the portfolio and ranks #4854 among its holdings. This is a return to the name: Barclays previously reported a position in ABEV as recently as Q3 2025.

Barclays first reported a position in ABEV in Q4 2013 and has held it in 42 quarters since. The position peaked at $12.9M in Q3 2015. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Barclays held 682 shares of Ambev worth $1.99K as of Q1 2026.
  • Ambev was a new Barclays position in Q1 2026.
  • Ambev made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4854 holding.
  • Barclays first reported a position in Ambev in Q4 2013 and has held it in 42 quarters since.
  • Barclays's Ambev position peaked at $12.9M in Q3 2015.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.